Product Information
RISEDRONATE SOD DR 35 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $27.4213 per EA under NDC 59762040704. Its NADAC has been published 430 times since Apr 4, 2018.
Strength
30.1; 4.9 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762040704
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RISEDRONATE SODIUM HEMIPENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022560On Market Since
3/2/2018
Pharmacological Classes
Price Statistics
The NADAC for RISEDRONATE SOD DR 35 MG TAB has been published 430 times since Apr 4, 2018, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $27.4213 per EA |
|---|---|
| All-time high | $37.4668 (Jan 15, 2020) |
| All-time low | $20.7485 (Nov 20, 2024) |
| 52-week high | $27.4213 |
| 52-week low | $23.8876 |
| Median price | $27.7950 |
| Average price | $28.7275 |
| Largest weekly change | +44.9% (Aug 19, 2020) |
| Weeks tracked | 430 |
| Tracking since | Apr 4, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RISEDRONATE SOD DR 35 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for RISEDRONATE SOD DR 35 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $27.4213 per EA (NDC 59762040704), effective Jun 24, 2026.
How has the price of RISEDRONATE SOD DR 35 MG TAB changed over time?
Over the history we have for it, the NADAC for RISEDRONATE SOD DR 35 MG TAB has declined 17.8%. It has been tracked across 430 weekly CMS publications since Apr 4, 2018.
What are the highest and lowest recorded NADAC prices for RISEDRONATE SOD DR 35 MG TAB?
Since Apr 4, 2018, the NADAC for RISEDRONATE SOD DR 35 MG TAB has ranged from a low of $20.7485 (Nov 20, 2024) to a high of $37.4668 (Jan 15, 2020), with a median of $27.7950 per EA.
Are there cheaper alternatives to RISEDRONATE SOD DR 35 MG TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as RISEDRONATE SOD DR 35 MG TAB, but none are currently priced below it.
Who manufactures RISEDRONATE SOD DR 35 MG TAB?
RISEDRONATE SOD DR 35 MG TAB (NDC 59762040704) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification